Tenax Therapeutics (TENX) Shares Outstanding (2011 - 2026)

Tenax Therapeutics' Shares Outstanding history runs 16 years deep, the most recent figure standing at $24.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 11559661.9% year-over-year to $24.3 million; the TTM figure through Mar 2026 stood at $24.3 million (up 11559661.9% YoY), while the FY2025 annual figure was $9.3 million, up 172.27% from the prior year.
• Shares Outstanding came in at $24.3 million for Q1 2026 at Tenax Therapeutics, up from $9.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $24.3 million in Q1 2026 to a low of $210.0 in Q1 2022.
• A 5-year average of $3.2 million and a median of $298281.0 in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding sank 99.99% in 2025 and jumped 11559661.9% in 2026, its largest moves.
• Tenax Therapeutics' Shares Outstanding stood at $28647.0 in 2022, then soared by 941.23% to $298281.0 in 2023, then jumped by 1046.87% to $3.4 million in 2024, then jumped by 172.27% to $9.3 million in 2025, then jumped by 160.63% to $24.3 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $24.3 million, $9.3 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison